Donepezil Completed Phase 2 Trials for Alzheimer's Disease (AD) / Mild-To-Moderate Alzheimer's Disease Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00710684A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease
NCT02337907BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
NCT00501111Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease
NCT00006399Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease
NCT00151398Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)
NCT00165659A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020
NCT00911807Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease
NCT00708552Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease
NCT01018875Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease
NCT00348192SB-742457 And Donepezil In Alzheimer's Disease
NCT00948909Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease
NCT01137526Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease
NCT01466088Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)
NCT01527916Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease